Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2020 Filed Jun 18, 2020 00:30 UTC |
RUPORT MARKDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 116,654 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001493152-20-011346 · ownership.xml · derivative · entry 1 RUPORT MARK · CIK 0001030874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,654 Underlying: Common Stock · 116,654 shares Expires 2025-05-27 F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on June 15, 2020. F2 · derivative.exercise_date: The stock option vests as follows: (i) 25% of the shares underlying the option vested on June 15, 2020, and (ii) the balance of the shares underlying the option will vest in equal (as closely as possible) monthly installments over three years from June 15, 2020, subject, in each case, to the Reporting Person being in the continous employ of the Issuer on the applicable vesting date. Read SEC document |
| June 15, 2020 Filed Jun 18, 2020 00:30 UTC |
Fisher Ronald Kenneth JrVP of Business Development
|
GrantStock Option (right to buy) · Derivative | 23,331 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001493152-20-011345 · ownership.xml · derivative · entry 1 Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,331 Underlying: Common Stock · 23,331 shares Expires 2025-05-27 F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on June 15, 2020. F2 · derivative.exercise_date: The stock option vests as follows: (i) 25% of the shares underlying the option vested on June 15, 2020, and (ii) the balance of the shares underlying the option will vest in equal (as closely as possible) monthly installments over three years from June 15, 2020, subject, in each case, to the Reporting Person being in the continous employ of the Issuer on the applicable vesting date. Read SEC document |
| May 01, 2020 Filed May 6, 2020 01:13 UTC |
Rice John ReynoldsDirector
|
GrantStock Option (right to buy) · Derivative | 16,044 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001493152-20-007777 · ownership.xml · derivative · entry 2 Rice John Reynolds · CIK 0001698204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,044 Underlying: Common Stock · 16,044 shares Expires 2025-04-30 Read SEC document |
| May 01, 2020 Filed May 6, 2020 01:13 UTC |
Rice John ReynoldsDirector
|
Disposition to issuerCommon Stock | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-007777 · ownership.xml · nonDerivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523 F1 · shares: The shares shown were forfeited in connection with the Reporting Person's resignation as an employee of the Issuer. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 22:00 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantCommon Stock | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-006418 · ownership.xml · nonDerivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,492 F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 22:00 UTC | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-006417 · ownership.xml · nonDerivative · entry 1 Beckett Darren · CIK 0001745828 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date. Read SEC document |
|
| April 10, 2020 Filed Apr 14, 2020 22:00 UTC |
Fisher Ronald Kenneth JrVP of Business Development
|
GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-006416 · ownership.xml · nonDerivative · entry 1 Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325 F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 22:00 UTC |
Orzechowski FrankCFO, PFO and PAO
|
GrantCommon Stock | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-006415 · ownership.xml · nonDerivative · entry 1 Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969 F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 22:00 UTC |
RUPORT MARKDirector · Executive Chairman
|
GrantCommon Stock | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-006414 · ownership.xml · nonDerivative · entry 1 RUPORT MARK · CIK 0001030874 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969 F1 · security: The shares shown were issued under the Issuer's 2013 Equity Incentive Plan. Such shares will vest in full on December 31, 2020, provided that the Reporting Person remains an employee of, or a consultant to, the Issuer through such vesting date. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
Battinelli Salvatore FDirector
|
GrantWarrants to Purchase Common Stock · Derivative | 24,272 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-20-003022 · ownership.xml · derivative · entry 2 Battinelli Salvatore F · CIK 0001714848 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,272 Underlying: Common Stock · 24,272 shares Expires 2025-07-28 F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
Battinelli Salvatore FDirector
|
GrantSeries E Preferred Stock · Derivative | 16.67 | $1,500.00 Strike: $1.03 | $25,005.00 |
DisclosureSEC source: 0001493152-20-003022 · ownership.xml · derivative · entry 1 Battinelli Salvatore F · CIK 0001714848 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16.67 Underlying: Common Stock · 31,756 shares Expires not disclosed F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
RUPORT MARKDirector · Executive Chairman
|
GrantWarrants to Purchase Common Stock · Derivative | 48,544 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-20-003021 · ownership.xml · derivative · entry 2 RUPORT MARK · CIK 0001030874 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,544 Underlying: Common Stock · 48,544 shares Expires 2025-07-28 F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
RUPORT MARKDirector · Executive Chairman
|
GrantSeries E Preferred Stock · Derivative | 33.33 | $1,500.00 Strike: $1.03 | $49,995.00 |
DisclosureSEC source: 0001493152-20-003021 · ownership.xml · derivative · entry 1 RUPORT MARK · CIK 0001030874 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33.33 Underlying: Common Stock · 63,494 shares Expires not disclosed F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
Garofalo Frank JFormer Director
|
GrantWarrants to Purchase Common Stock · Derivative | 24,272 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 2 Garofalo Frank J · CIK 0001698160 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,272 Underlying: Common Stock · 24,272 shares Expires 2025-07-28 F1 · price: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. Read SEC document |
| January 28, 2020 Filed Feb 26, 2020 23:05 UTC |
Garofalo Frank JFormer Director
|
GrantSeries E Preferred Stock · Derivative | 16.67 | $1,500.00 Strike: $1.03 | $25,005.00 |
DisclosureSEC source: 0001493152-20-003020 · ownership.xml · derivative · entry 1 Garofalo Frank J · CIK 0001698160 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16.67 Underlying: Common Stock · 31,756 shares Expires not disclosed F1 · security: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F1 · derivative.expiration_date: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date. F2 · derivative.underlying_shares: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1. Read SEC document |
| January 28, 2020 Filed Feb 11, 2021 21:45 UTC |
Schwartz Carl I.Former 10% holder
|
PurchaseWarrants to Purchase Common Stock · Derivative | 38,835 | Not disclosed Strike: $11.13 | Not disclosed |
DisclosureSEC source: 0001179110-21-001589 · edgar.xml · derivative · entry 4 Schwartz Carl I. · CIK 0001573354 · Former 10% holder 10b5-1 filing: Not disclosed Ownership: Indirect · By Carl & Shirley Schwartz Trust Disclosed balance after: 38,835 Underlying: Common Stock · 38,835 shares Expires 2025-07-26 F4 · derivative.exercise_price: Conversion and exercise prices have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020. F3 · price: Purchase was made in conjunction with purchase of Series E Convertible Preferred Stock. F1 · derivative.underlying_shares: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020. F1 · balance_after: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020. Read SEC document |
| January 28, 2020 Filed Feb 11, 2021 21:45 UTC |
Schwartz Carl I.Former 10% holder
|
PurchaseSeries E Convertible Preferred Stock · Derivative | 266.67 | $1,500.00 Strike: $10.30 | $400,005.00 |
DisclosureSEC source: 0001179110-21-001589 · edgar.xml · derivative · entry 3 Schwartz Carl I. · CIK 0001573354 · Former 10% holder 10b5-1 filing: Not disclosed Ownership: Indirect · By Carl & Shirley Schwartz Trust Disclosed balance after: 266.67 Underlying: Common Stock · 38,835 shares Expires not disclosed F4 · derivative.exercise_price: Conversion and exercise prices have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020. F2 · derivative.expiration_date: No expiration date. F1 · derivative.underlying_shares: Share ownership totals have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on February 27, 2020. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 23:44 UTC |
RUPORT MARKDirector · Executive Chairman
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001250853-19-000110 · primary_doc.xml · derivative · entry 2 RUPORT MARK · CIK 0001030874 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2024-12-02 F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal (as closely as possible) monthly installments over three years from the Grant Date, subject to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 23:44 UTC |
RUPORT MARKDirector · Executive Chairman
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001250853-19-000110 · primary_doc.xml · derivative · entry 1 RUPORT MARK · CIK 0001030874 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2024-12-02 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on the one month anniversary of December 3, 2019 (the "Grant Date") Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 23:16 UTC | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001250853-19-000101 · primary_doc.xml · derivative · entry 1 Beckett Darren · CIK 0001745828 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-10 Read SEC document |
|
| August 09, 2019 Filed Aug 16, 2019 15:11 UTC |
Schwartz Carl I.Director · Chief Executive Officer
|
PurchaseCommon Stock | 62,433 | $0.75 | $46,824.75 |
DisclosureSEC source: 0001179110-19-009568 · edgar.xml · nonDerivative · entry 4 Schwartz Carl I. · CIK 0001573354 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Read SEC document |
| August 09, 2019 Filed Aug 22, 2019 16:07 UTC Amendment |
Schwartz Carl I.10% owner
|
PurchaseCommon Stock | 62,433 | $0.75 | $46,824.75 |
DisclosureSEC source: 0001179110-19-009767 · edgar.xml · nonDerivative · entry 4 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Read SEC document |
| August 08, 2019 Filed Aug 16, 2019 15:11 UTC |
Schwartz Carl I.Director · Chief Executive Officer
|
PurchaseCommon Stock | 437,567 | $0.69 | $301,921.23 |
DisclosureSEC source: 0001179110-19-009568 · edgar.xml · nonDerivative · entry 3 Schwartz Carl I. · CIK 0001573354 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,937,567 Read SEC document |
| August 08, 2019 Filed Aug 22, 2019 16:07 UTC Amendment |
Schwartz Carl I.10% owner
|
PurchaseCommon Stock | 437,567 | $0.69 | $301,921.23 |
DisclosureSEC source: 0001179110-19-009767 · edgar.xml · nonDerivative · entry 3 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,937,567 Read SEC document |
| August 01, 2019 Filed Aug 9, 2019 21:49 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,922 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001250853-19-000096 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,922 Underlying: Common Stock · 22,922 shares Expires 2024-07-31 Read SEC document |
| July 18, 2019 Filed Jul 23, 2019 01:10 UTC | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001250853-19-000092 · primary_doc.xml · derivative · entry 1 Beckett Darren · CIK 0001745828 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2024-07-17 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in four annual installments of 1,250 shares each over four years from the date of grant; provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date. Read SEC document |
|
| July 18, 2019 Filed Jul 23, 2019 00:51 UTC |
Orzechowski FrankCFO, PFO and PAO
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001250853-19-000091 · primary_doc.xml · derivative · entry 2 Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2024-06-30 F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019. F2 · derivative.exercise_date: The stock option vests as follows: 3,872 shares will vest and become exercisable on July 1, 2020; 9,000 shares will vest and become exercisable on July 1, 2021; 14,128 shares will vest and become exercisable on July 1, 2022, and 33,000 shares will vest and become exercisable on July 1, 2023, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date. Read SEC document |
| July 18, 2019 Filed Jul 23, 2019 00:51 UTC |
Orzechowski FrankCFO, PFO and PAO
|
GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001250853-19-000091 · primary_doc.xml · derivative · entry 1 Orzechowski Frank · CIK 0001781860 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2024-06-30 F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019. Read SEC document |
| July 18, 2019 Filed Jul 23, 2019 00:12 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001250853-19-000090 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-06-30 F1 · date: The option grant was previously approved by a committee of the Issuer's Board of Directors, subject to stockholder approval of an amendment to the Issuer's equity incentive plan under which the option was granted. The Issuer's stockholders approved the amendment on July 18, 2019. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 21:38 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001250853-19-000072 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-05-31 Read SEC document |
| May 07, 2019 Filed May 23, 2019 21:25 UTC |
Schwartz Carl I.10% owner
|
PurchaseWarrants to purchase Common Stock · Derivative | 200,000 | Not disclosed Strike: $1.56 | Not disclosed |
DisclosureSEC source: 0001179110-19-006589 · edgar.xml · derivative · entry 3 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Carl I. Schwartz Revocable Family Trust dtd 03/14/19 Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2024-11-08 F1 · price: Purchase price included 200,000 Warrants reported on table II. F2 · derivative.exercise_date: Warrant contains a Beneficial Ownership Limitation provision that does not permit an exercise if it would result in the holder owning more than 4.99% of the outstanding shares of the Issuer. These limits may be increased up to 9.99% upon notice to the Issuer. Read SEC document |
| May 07, 2019 Filed May 23, 2019 21:25 UTC |
Schwartz Carl I.10% owner
|
PurchaseCommon Stock | 400,000 | $1.40 | $560,000.00 |
DisclosureSEC source: 0001179110-19-006589 · edgar.xml · nonDerivative · entry 2 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Carl I. Schwartz Revocable Family Trust dtd 3/14/19 Disclosed balance after: 400,000 F1 · price: Purchase price included 200,000 Warrants reported on table II. Read SEC document |
| May 07, 2019 Filed May 24, 2019 15:46 UTC Amendment |
Schwartz Carl I.10% owner
|
PurchaseWarrants to purchase Common Stock · Derivative | 200,000 | Not disclosed Strike: $1.56 | Not disclosed |
DisclosureSEC source: 0001179110-19-006622 · edgar.xml · derivative · entry 3 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Carl and Shirley Schwartz Trust dtd 3/14/19 Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2024-11-08 F1 · price: Purchase price included 200,000 Warrants reported on table II. F2 · derivative.exercise_date: Warrant contains a Beneficial Ownership Limitation provision that does not permit an exercise if it would result in the holder owning more than 4.99% of the outstanding shares of the Issuer. These limits may be increased up to 9.99% upon notice to the Issuer. Read SEC document |
| May 07, 2019 Filed May 24, 2019 15:46 UTC Amendment |
Schwartz Carl I.10% owner
|
PurchaseCommon Stock | 400,000 | $1.40 | $560,000.00 |
DisclosureSEC source: 0001179110-19-006622 · edgar.xml · nonDerivative · entry 2 Schwartz Carl I. · CIK 0001573354 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By the Carl and Shirley Schwartz Trust dtd 3/14/19 Disclosed balance after: 400,000 F1 · price: Purchase price included 200,000 Warrants reported on table II. Read SEC document |
| May 01, 2019 Filed May 2, 2019 22:06 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001250853-19-000066 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-04-30 Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 23:54 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001250853-19-000062 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-03-29 Read SEC document |
| March 07, 2019 Filed Mar 29, 2019 22:32 UTC |
Fisher Ronald Kenneth JrVP of Business Development
|
GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000058 · primary_doc.xml · nonDerivative · entry 2 Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F2 · shares: The shares shown represent a stock award based on an applicable milestone being achieved. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 02:15 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001250853-19-000047 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-02-29 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 23:02 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001250853-19-000037 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2024-01-31 Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:18 UTC |
Fisher Ronald Kenneth JrVP of Business Development
|
GrantStock Option (right to buy) · Derivative | 11,832 | $0.00 Strike: $2.02 | $0.00 |
DisclosureSEC source: 0001250853-19-000030 · primary_doc.xml · derivative · entry 1 Fisher Ronald Kenneth Jr · CIK 0001698203 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,832 Underlying: Common Stock · 11,832 shares Expires 2024-01-09 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 02:28 UTC | GrantStock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001250853-19-000007 · primary_doc.xml · derivative · entry 1 Beckett Darren · CIK 0001745828 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2023-12-31 F1 · derivative.exercise_date: (1) The stock option vests and becomes exercisable in four annual installments over four years from the date of grant, as follows: 937 shares will vest and become exercisable on December 31, 2019; 937 shares will vest and become exercisable on December 31, 2020; 938 shares will vest and become exercisable on December 31, 2021; and 938 shares will vest and become exercisable on December 31, 2022; provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date. Read SEC document |
|
| January 01, 2019 Filed Jan 4, 2019 01:53 UTC |
Toups NannetteCFO, PFO and PAO
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001250853-19-000006 · primary_doc.xml · derivative · entry 1 Toups Nannette · CIK 0001718563 · CFO, PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-12-31 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in four equal annual installments of 12,500 shares each over four years from the date of grant, beginning on December 31, 2019, provided, in each case, that the Reporting Person remains an employee of the Issuer through such vesting date. Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 01:27 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001250853-19-000005 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2023-12-31 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 01:11 UTC |
Summers Kent JDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000004 · primary_doc.xml · nonDerivative · entry 1 Summers Kent J · CIK 0001728948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:53 UTC |
Garofalo Frank JDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000003 · primary_doc.xml · nonDerivative · entry 1 Garofalo Frank J · CIK 0001698160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:24 UTC |
Battinelli Salvatore FDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000002 · primary_doc.xml · nonDerivative · entry 1 Battinelli Salvatore F · CIK 0001714848 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,213 Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:03 UTC |
Duitch DennisDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-19-000001 · primary_doc.xml · nonDerivative · entry 1 Duitch Dennis · CIK 0001352880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,489 Read SEC document |
| December 01, 2018 Filed Dec 5, 2018 01:12 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 22,916 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001250853-18-000146 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: Common Stock · 22,916 shares Expires 2023-12-01 Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 22:21 UTC |
Rice John ReynoldsDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 68,750 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001250853-18-000138 · primary_doc.xml · derivative · entry 1 Rice John Reynolds · CIK 0001698204 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: Common Stock · 68,750 shares Expires 2023-11-01 Read SEC document |
| October 18, 2018 Filed Oct 23, 2018 00:16 UTC | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001250853-18-000133 · primary_doc.xml · derivative · entry 1 Beckett Darren · CIK 0001745828 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-10-17 F1 · derivative.exercise_date: The stock option vests as follows: 1,000 shares will vest and become exercisable on Sepetember 16, 2019; 3,000 shares will vest and become exercisable on September 16, 2020; 5,000 shares will vest and become exercisable on September 16, 2021, and 11,000 shares will vest and become exercisable on September 16, 2022, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.